ECO 2026 12 - 15 May 2026

Assessing Cardiovascular Safety and Outcomes With the Combination of Cagrilintide and Semaglutide (CagriSema): REDEFINE 3 Randomised Clinical Trial Baseline Characteristics and Methods

Authors :

Matthew A. Cavender¹; Ania M. Jastreboff²; Alice Y. Y. Cheng³; Melanie J. Davies^4,5; Lucienne Donaldson⁶; Lars-Ole Gerlach⁶; Silas Hinsch Gylvin⁶; Jacob Bonde Jacobsen⁶; Nikolaus Marx⁷; Cynthia Karenina Osorto Contreras⁶; Carel W. Le Roux8, A. Michael Lincoff⁹